genetic engineering

genetic engineering is the direct manipulation of an organism's genome using biotechnology. It involves the targeted alteration, insertion, or deletion of DNA sequences to change an organism's characteristics. The field emerged from foundational discoveries in molecular biology and has since enabled significant advances in medicine, agriculture, and industrial biotechnology.

History

The conceptual foundations were laid with the identification of DNA as the genetic material by Oswald Avery and colleagues, followed by the elucidation of its double-helix structure by James Watson and Francis Crick. Key enabling tools were developed in the 1970s, including restriction enzymes discovered by Werner Arber and Daniel Nathans, and the creation of recombinant DNA by Paul Berg and Stanley Cohen. The first commercial application was the production of human insulin by Genentech in 1978. The field accelerated with the invention of the polymerase chain reaction by Kary Mullis and culminated in large-scale projects like the Human Genome Project, led by institutions such as the National Institutes of Health and the Wellcome Trust.

Techniques

Core methodologies involve the use of restriction enzymes and DNA ligase to cut and splice genes, a process central to creating recombinant DNA. Vectors, such as those derived from the Ti plasmid of Agrobacterium tumefaciens or engineered bacteriophage, are used to introduce foreign DNA into host cells. More recent, precise tools include CRISPR-Cas9, a system adapted from the immune system of Streptococcus pyogenes, and zinc finger nucleases developed by researchers like J. Keith Joung. Other advanced techniques involve gene targeting in models like the mouse and the use of antisense RNA for gene silencing.

Applications

In medicine, it has enabled the production of therapeutics like human growth hormone and tissue plasminogen activator, and is central to developing gene therapy for conditions such as severe combined immunodeficiency. Agricultural applications include crops like Flavr Savr tomato, Golden Rice developed by the International Rice Research Institute, and Bt corn engineered for pest resistance. In industry, modified microorganisms are used to produce substances like rennet for cheese-making and biofuels. Research institutions, including the Broad Institute and the Salk Institute, actively pursue these applications.

Regulation and ethics

Governance frameworks vary globally. In the United States, oversight involves the Food and Drug Administration, the United States Department of Agriculture, and the Environmental Protection Agency. The European Union operates under directives like the Deliberate Release Directive. International agreements such as the Cartagena Protocol on Biosafety govern transboundary movements. Ethical debates often reference the Asilomar Conference on Recombinant DNA, which established early guidelines. Ongoing discussions involve bodies like the Nuffield Council on Bioethics and concern issues like germline modification, recently highlighted by the work of He Jiankui.

Controversies

Major debates surround the release of genetically modified organisms into the environment, with events like the Starlink corn recall highlighting concerns about allergenicity and ecological impact. The use of terminator technology has sparked disputes over farmers' rights and biodiversity, often involving groups like Monsanto and Via Campesina. Human applications remain highly contentious, as seen in the international condemnation of He Jiankui's CRISPR-edited babies. Broader socio-economic concerns include corporate control of the food supply, as debated in cases like Bowman v. Monsanto Co., and labeling campaigns such as Proposition 37 in California.

Category:Biotechnology